A recent study found that reducing TN-C expression in cancer cells can enhance the efficacy of inhibitors targeting the ErbB3, PI3K-AKT, Ras, and MAPK signalling pathways in oesophageal squamous cell carcinoma [146]. This evidence concerns the gene AKT1 and cancer.